Antonio Regolado in MIT Technology Review:
https://www.technologyreview.com/2023/12/07/1084629/lucky-break-crispr-vertex/
The UK has already approved one of them. The matching FDA decision is coming up this Friday. There will be another one by 20 December. Both treatments are for sickle cell disease but they can come at the expense of the person’s fertility and certainly the first one requires a long period of hospitalization.
CRISPR is what sparked this book:
